BTK inhibitor

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Global Trial in APG2575 for Patients With CLL/SLLNCT06104566Ascentage Pharma Group Inc.Phase 3Recruiting2026-12-31Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.